Progressing Clinical Evidence: CathVision Announces First Patient Enrolled In Persistent AF Study at OLV Hospital Aalst
/PRNewswire/ -- CathVision, a medical technology company developing innovative electrophysiology solutions to enhance clinical decision-making in the EP lab,...
Source: prnewswire.com